Posts By Alex
-
611Wire StoriesCelltrion Initiates Post-exposure Prophylaxis Clinical Trial of an Anti-COVID-19 Monoclonal Antibody Treatment Candidate, CT-P59
The Korean Ministry of Food and Drug Safety (MFDS) has approved Celltrion�s Investigational New Drug (IND) application to initiate the post-exposure prophylaxis...
-
731Wire Stories
MackeyRMS Introduces ESG Scorecards to Streamline Investment Selection, Monitoring and Reporting for ESG-Focused Portfolios
The Release of ESG Scorecards Comes as Funds Applying ESG Investment Criteria Topped $1 Trillion AUM in Q2 2020 BOSTON–(BUSINESS WIRE)–MackeyRMS, a...
-
777Wire Stories
Cloudflare Announces Cloudflare One, a Platform to Connect and Secure Companies and Remote Teams Anywhere, On Any Device
New platform uses a Zero Trust security model to provide an easy and reliable way for companies of all sizes to protect...
-
670Wire Stories
Dr. Reddy’s to Release Q2 FY 21 Results on October 28th, 2020
Earnings call slated for October 28th @ 5:30 PM IST / 8:00 AM EDT HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124,...
-
699Wire Stories
Granite Awarded $16 Million Task Order Contract by the Federal Emergency Management Agency
WATSONVILLE, Calif.–(BUSINESS WIRE)–#SafetyByChoice–Granite (NYSE:GVA) announced it has been awarded a $16 million task order contract by the U.S. Department of Homeland Security�s...
-
730Wire Stories
Velodyne Lidar Announces Three-Year Sales Agreement with Baidu
SAN JOSE, Calif.–(BUSINESS WIRE)–#lidar—Velodyne Lidar, Inc. (Nasdaq: VLDR) today announced a three-year sales agreement with Baidu for its Alpha Prime� lidar sensors....
-
670Wire Stories
Seagen and Astellas Announce Positive Topline Results from Second Cohort of Patients in Phase 2 Pivotal Trial of PADCEV� (enfortumab vedotin-ejfv) in Advanced Urothelial Cancer
– Durable Responses Observed in Patients Who Had Previously Received Immunotherapy but Were Ineligible for Cisplatin in Locally Advanced or Metastatic Setting...
-
702Wire Stories
HitGen to Acquire Vernalis, a Leader in Structure-Based Drug Discovery
CHENGDU, China–(BUSINESS WIRE)–HITGEN (688222.SH) announces it has entered into a definitive agreement with Ligand Pharmaceuticals Inc. (NASDAQ: LGND) to acquire Vernalis (R&D)...
-
639Wire Stories
Honor Watch GS Pro & HONOR Watch ES–Move More to Explore
SHENZHEN, China–(BUSINESS WIRE)–People with great enthusiasm and curiosity never stop to explore the world, although they live in concrete jungles. Designed especially...
-
775Wire Stories
Food-e, Japan�s First Gourmet Restaurant Delivery App, Launches Today
TOKYO–(BUSINESS WIRE)–Starting today, Tokyo foodies will no longer have to compromise when they order food for delivery. Japan�s first gourmet restaurant delivery...
